Abstract
The different base-promoted regioselective reactions between dialkyl (2E,3E)-2-[(dimethylamino)methylene]-3-(1-methyl-2,5- dioxoimidazolidin-4-ylidene)succinates and 1,2-diaza-1,3-dienes are investigated. Under the appropriate reaction conditions it is possible to turn the synthesis towards 1,3-dioxo-2,3,7,7a-tetrahydro-1H-pyrrolo[1,2-c]imidazoles or 1,3-dioxo-1,2,3,5-tetrahydroimidazo[1,5- a]pyridines. Both these transformations proceed via a double-Michael-addition.
Keywords: Cyclization, 1, 2-Diaza-1, 3-dienes, 2, 5-Dioxoimidazolidin-4-ylidene-succinates, Fused-ring systems, Michael addition, Nitrogen heterocycles.
Current Organic Synthesis
Title:Divergent Behavior of the Reactions Between 1,2-Diaza-1,3-dienes and 2,5- Dioxoimidazolidin-4-ylidene-succinates
Volume: 10 Issue: 3
Author(s): Orazio A. Attanasi, Luca Bianchi, Jure Bezensek, Gianfranco Favi, Gianluca Giorgi, Fabio Mantellini, Branko Stanovnik and Jurij Svete
Affiliation:
Keywords: Cyclization, 1, 2-Diaza-1, 3-dienes, 2, 5-Dioxoimidazolidin-4-ylidene-succinates, Fused-ring systems, Michael addition, Nitrogen heterocycles.
Abstract: The different base-promoted regioselective reactions between dialkyl (2E,3E)-2-[(dimethylamino)methylene]-3-(1-methyl-2,5- dioxoimidazolidin-4-ylidene)succinates and 1,2-diaza-1,3-dienes are investigated. Under the appropriate reaction conditions it is possible to turn the synthesis towards 1,3-dioxo-2,3,7,7a-tetrahydro-1H-pyrrolo[1,2-c]imidazoles or 1,3-dioxo-1,2,3,5-tetrahydroimidazo[1,5- a]pyridines. Both these transformations proceed via a double-Michael-addition.
Export Options
About this article
Cite this article as:
A. Attanasi Orazio, Bianchi Luca, Bezensek Jure, Favi Gianfranco, Giorgi Gianluca, Mantellini Fabio, Stanovnik Branko and Svete Jurij, Divergent Behavior of the Reactions Between 1,2-Diaza-1,3-dienes and 2,5- Dioxoimidazolidin-4-ylidene-succinates, Current Organic Synthesis 2013; 10 (3) . https://dx.doi.org/10.2174/1570179411310030009
DOI https://dx.doi.org/10.2174/1570179411310030009 |
Print ISSN 1570-1794 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6271 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
Current Pharmaceutical Design Targeting DNA Repair Systems in Antitubercular Drug Development
Current Medicinal Chemistry Activation of Macrophages: Establishing a Role for Polysaccharides in Drug Delivery Strategies Envisaging Antibacterial Therapy
Current Pharmaceutical Design Developing Solid Particulate Vaccine Adjuvants: Surface Bound Antigen Favours a Humoural Response, whereas Entrapped Antigen Shows a Tendency for Cell Mediated Immunity
Current Drug Delivery Quinoline – a Promising Fragment in the Search for New Antimalarials
Mini-Reviews in Medicinal Chemistry Mechanism of Bioactive Transfer through Liposomal Bilayers
Current Drug Targets From Conventional Reaction Conditions to Microwave-Assisted Catalytic Transformations of Various Substrates. State of the Art in 2012 (Part A: General)
Current Organic Chemistry Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health
Current Pharmacogenomics and Personalized Medicine Editorial (Thematic Issue: Techniques and Application in Metabolomics: From Metabolite Profiling to Spatial Distribution)
Current Metabolomics Targeting InhA, the FASII Enoyl-ACP Reductase: SAR Studies on Novel Inhibitor Scaffolds
Current Topics in Medicinal Chemistry Design of Lipophilic Prodrugs to Improve Drug Delivery and Efficacy
Current Drug Targets Subject Index to Volume 1
Letters in Drug Design & Discovery Comparison of Protease Inhibitor (PI) Resistance-Associated Mutations Between PI-Naive and PI-Experienced HIV-1 Infected Patients in Thailand Where Subtype A/E is Predominant
Current HIV Research IL-1 as a target in inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Design, Synthesis and Evaluation of Thiourea Derivatives as Antimicrobial and Antiviral Agents
Letters in Drug Design & Discovery Editorial
Current Drug Therapy Synthesis, <i>In silico</i> and <i>In vitro</i> Analysis of Hydrazones as Potential Antituberculosis Agents
Current Computer-Aided Drug Design Biodegradable Polymeric Nanoparticles as the Delivery Carrier for Drug
Current Drug Delivery Therapeutic Potential of Cholesteryl O-acyl α-glucoside Found in Helicobacter pylori
Current Medicinal Chemistry Formulation of Nanosuspensions as a New Approach for the Delivery of Poorly Soluble Drugs
Current Nanoscience